Swenson DL - Search Results

1

Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, Nichols DK, Iversen PL, Bavari S. Warren TK, et al. Among authors: swenson dl. Nat Med. 2010 Sep;16(9):991-4. doi: 10.1038/nm.2202. Epub 2010 Aug 22. Nat Med. 2010. PMID: 20729866

2

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.

Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S. Swenson DL, et al. Vaccine. 2005 Apr 27;23(23):3033-42. doi: 10.1016/j.vaccine.2004.11.070. Vaccine. 2005. PMID: 15811650

3

Filovirus-like particles as vaccines and discovery tools.

Warfield KL, Swenson DL, Demmin G, Bavari S. Warfield KL, et al. Among authors: swenson dl. Expert Rev Vaccines. 2005 Jun;4(3):429-40. doi: 10.1586/14760584.4.3.429. Expert Rev Vaccines. 2005. PMID: 16026254 Review.

4

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iversen PL, Bavari S. Warfield KL, et al. Among authors: swenson dl. PLoS Pathog. 2006 Jan;2(1):e1. doi: 10.1371/journal.ppat.0020001. Epub 2006 Jan 13. PLoS Pathog. 2006. PMID: 16415982 Free PMC article.

5

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.

Warfield KL, Posten NA, Swenson DL, Olinger GG, Esposito D, Gillette WK, Hopkins RF, Costantino J, Panchal RG, Hartley JL, Aman MJ, Bavari S. Warfield KL, et al. Among authors: swenson dl. J Infect Dis. 2007 Nov 15;196 Suppl 2:S421-9. doi: 10.1086/520612. J Infect Dis. 2007. PMID: 17940979

6

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S. Warfield KL, et al. Among authors: swenson dl. J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7. doi: 10.1086/520583. J Infect Dis. 2007. PMID: 17940980

7

Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.

Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD. Swenson DL, et al. Clin Vaccine Immunol. 2008 Mar;15(3):460-7. doi: 10.1128/CVI.00431-07. Epub 2008 Jan 23. Clin Vaccine Immunol. 2008. PMID: 18216185 Free PMC article.

8

Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.

Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN, Ruthel G, Blouch RE, Moulton HM, Weller DD, Iversen PL, Bavari S. Swenson DL, et al. Antimicrob Agents Chemother. 2009 May;53(5):2089-99. doi: 10.1128/AAC.00936-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223614 Free PMC article.

9

Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.

Warfield KL, Dye JM, Wells JB, Unfer RC, Holtsberg FW, Shulenin S, Vu H, Swenson DL, Bavari S, Aman MJ. Warfield KL, et al. Among authors: swenson dl. PLoS One. 2015 Mar 20;10(3):e0118881. doi: 10.1371/journal.pone.0118881. eCollection 2015. PLoS One. 2015. PMID: 25793502 Free PMC article.

10

AVI-7288 for Marburg Virus in Nonhuman Primates and Humans.

Heald AE, Charleston JS, Iversen PL, Warren TK, Saoud JB, Al-Ibrahim M, Wells J, Warfield KL, Swenson DL, Welch LS, Sazani P, Wong M, Berry D, Kaye EM, Bavari S. Heald AE, et al. Among authors: swenson dl. N Engl J Med. 2015 Jul 23;373(4):339-48. doi: 10.1056/NEJMoa1410345. N Engl J Med. 2015. PMID: 26200980 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page